Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator agent with beta-adrenergic agonist properties. It is believed to exert its effects by relaxing smooth muscle in blood vessels, leading to vasodilation.
## Primary Indications
* Treatment of peripheral vascular disease, including intermittent claudication and Raynaud's disease.
* Management of cerebrovascular insufficiency.
## Adult Dosing
* Oral: 10 mg to 20 mg three to four times daily.
* Maximum dose: Not well-established, but doses above 20 mg per administration are generally not recommended.
## Pediatric Dosing
* Dosing in pediatric patients is not established. Safety and efficacy have not been determined.
## Dose Adjustments
* Renal impairment: No specific guidelines. Use with caution and monitor for adverse effects.
* Hepatic impairment: No specific guidelines. Use with caution and monitor for adverse effects.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use with extreme caution in patients with significant hypotension or tachycardia.
## Adverse Effects
* Common: Nausea, vomiting, dizziness, flushing, drowsiness, weakness, headache, rash.
* Less common: Hypotension, tachycardia, gastrointestinal distress, blurred vision.
## Key Drug Interactions
* Antihypertensives: Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* Other vasodilators: Concomitant use may lead to additive hypotensive effects.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease.
* Patient's response to therapy.
## Clinical Pearls
* The efficacy of isoxsuprine in treating peripheral vascular disease is controversial, and its use has declined significantly due to a lack of robust evidence supporting its benefit.
* It should not be used as a substitute for proper wound care, exercise, or smoking cessation in patients with peripheral artery disease.
***
**Disclaimer:** This information is intended for healthcare professionals. Please consult the most current prescribing information and relevant clinical guidelines for complete details, as recommendations may vary based on local protocols and evolving clinical evidence.
